• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单次剂量血管加压素类似物对人体肾脏钾排泄的影响。

The influence of a single dose of vasopressin analogs on human renal potassium excretion.

作者信息

Nádvorníková H, Schück O

出版信息

Int J Clin Pharmacol Ther Toxicol. 1982 Apr;20(4):155-8.

PMID:7076344
Abstract

The effect of intranasal administration of 10 micrograms of 1-deamino-8-d-arginine vasopressin (DDAVP) and intravenous administration of 200 micrograms of N-glycyl-glycyl-glycyl-lysin-vasopressin (TGLVP) on urinary concentration (UK) and fractional excretion (FEK) of potassium was investigated in healthy subjects. For comparison the same parameters were followed under conditions of 36-h water-intake restriction. Once the maximally concentrated urine had been reached, the average value of UK after DDAVP administration was 108 +/- 45 mmol/l and after TGLVP administration 102 +/- 48 mmol/l. These values are significantly higher (p less than 0.001) than the average value of UK observed under conditions of water deprivation (58 +/- 22 mol/l). The average value of FEK after DDAVP administration was 14.8 +/- 6.3% and after TGLVP administration, 14.9 +/- 6.5%. These values are also significantly higher (p less than 0.001) than the average values of FEK observed under control conditions (9.3 +/- 5.5%) The effect of DDAVP on UK and FEK was related to the age of the investigated subjects. The most pronounced changes were observed in younger individuals. The influence of vasopressin analogs on UK and FEK could not be explained on the basis of changes in urinary osmolarity, sodium excretion, or fractional water excretion. The results obtained are compatible with the hypothesis that DDAVP and TGLVP increase the tubular secretion of potassium. The mechanism of action has to be elucidated by further research.

摘要

在健康受试者中,研究了经鼻给予10微克1-去氨基-8-D-精氨酸加压素(DDAVP)和静脉给予200微克N-甘氨酰-甘氨酰-甘氨酰-赖氨酸加压素(TGLVP)对尿钾浓度(UK)和钾排泄分数(FEK)的影响。为作比较,在36小时限水条件下观察相同参数。一旦达到最大浓缩尿,给予DDAVP后UK的平均值为108±45 mmol/L,给予TGLVP后为102±48 mmol/L。这些值显著高于(p<0.001)禁水条件下观察到的UK平均值(58±22 mmol/L)。给予DDAVP后FEK的平均值为14.8±6.3%,给予TGLVP后为14.9±6.5%。这些值也显著高于(p<0.001)对照条件下观察到的FEK平均值(9.3±5.5%)。DDAVP对UK和FEK的影响与被研究受试者的年龄有关。在较年轻个体中观察到最明显的变化。血管加压素类似物对UK和FEK的影响不能根据尿渗透压、钠排泄或水排泄分数的变化来解释。所得结果与DDAVP和TGLVP增加肾小管钾分泌的假说相符。其作用机制有待进一步研究阐明。

相似文献

1
The influence of a single dose of vasopressin analogs on human renal potassium excretion.单次剂量血管加压素类似物对人体肾脏钾排泄的影响。
Int J Clin Pharmacol Ther Toxicol. 1982 Apr;20(4):155-8.
2
[Experiences with the intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP)--effect of one time parenteral and intranasal applications].[1-去氨基-8-D-精氨酸加压素(DDAVP)鼻内及肠胃外使用的经验——单次肠胃外及鼻内应用的效果]
Z Gesamte Inn Med. 1983 Aug 15;38(16):450-2.
3
Effects of lysine-vasopressin (LVP) and 1-deamino-8-D-arginine-vasopressin (dDAVP) upon electrical potential, short-circuit current and transepithelial D.C. resistance of the frog skin.赖氨酸加压素(LVP)和1-去氨基-8-D-精氨酸加压素(dDAVP)对蛙皮电势、短路电流和跨上皮直流电阻的影响。
Gen Physiol Biophys. 1984 Aug;3(4):297-305.
4
Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.去氨基 - 8 - D - 精氨酸加压素对遗传性尿崩症大鼠肾前列腺素合成的剂量依赖性刺激作用。
J Pharmacol Exp Ther. 1981 Apr;217(1):87-91.
5
The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.1-去氨基-8-D-精氨酸加压素(DDAVP)对人体的抗利尿作用。
Int J Clin Pharmacol Biopharm. 1976 Apr;13(3):199-209.
6
The urinary excretion of selenium in sheep treated with a vasopressin analogue.用一种加压素类似物处理的绵羊中硒的尿排泄情况。
Vet Res. 2000 Sep-Oct;31(5):499-505. doi: 10.1051/vetres:2000101.
7
Comparison of antidiuretic and natriuretic effects of [8-lysine]vasopressin and [8-D-arginine]deaminovasopressin in conscious rats.[8-赖氨酸]加压素和[8-D-精氨酸]去氨加压素对清醒大鼠抗利尿和利钠作用的比较。
Endocrinol Exp. 1981;15(2):129-38.
8
Detection of renal impairment in cases of chronic abuse of analgesics by administration of desamino-D-arginine vasopressin.通过给予去氨基-D-精氨酸血管加压素检测慢性滥用镇痛药病例中的肾功能损害。
Arzneimittelforschung. 1989 Mar;39(3):387-90.
9
Effects of lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients.赖氨酸加压素和1-去氨基-8-D-精氨酸加压素对健康个体及尿崩症患者记忆的影响。
Psychoneuroendocrinology. 1982;7(2-3):185-93. doi: 10.1016/0306-4530(82)90011-7.
10
[Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in a simple test of renal concentrating ability].
Z Gesamte Inn Med. 1984 Jun 1;39(11):265-8.

引用本文的文献

1
Baseline Renal Function Predicts Hyponatremia in Liver Cirrhosis Patients Treated with Terlipressin for Variceal Bleeding.基线肾功能可预测接受特利加压素治疗静脉曲张出血的肝硬化患者的低钠血症。
Gastroenterol Res Pract. 2017;2017:7610374. doi: 10.1155/2017/7610374. Epub 2017 Sep 17.
2
Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists.血管加压素和选择性血管加压素受体拮抗剂作用下的钠排泄
J Am Soc Nephrol. 2008 Sep;19(9):1721-31. doi: 10.1681/ASN.2008010021. Epub 2008 Jul 2.